CAMBRIDGE, Mass., April 22, 2024 /PRNewswire/ NeuroSense Therapeutics Ltd. , a company developing novel treatments for severe neurodegenerative diseases announced today a collaboration in.
NeuroSense Therapeutics Ltd. (NASDAQ:NRSNW – Get Free Report) was the target of a significant decline in short interest in March. As of March 31st, there was short interest totalling 1,800 shares, a decline of 57.1% from the March 15th total of 4,200 shares. Based on an average daily volume of 10,000 shares, the short-interest ratio […]
NeuroSense to Present PARADIGM Data at the American Academy of Neurology Annual Meeting April 16, 2024 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense" or the "Company"), a company developing novel treatments for severe neurodegenerative.